ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

EDIT Editas Medicine Inc

5.54
0.33 (6.33%)
02 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Editas Medicine Inc EDIT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.33 6.33% 5.54 08:56:42
개장가 저가 고가 종가 전일 종가
5.21 5.21 5.67 5.47 5.21
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202421:00GLOBEEditas Medicine and Bristol Myers Squibb Extend Alpha-Beta T..
23/04/202405:31GLOBEEditas Medicine to Present Pre-clinical Data Demonstrating..
06/03/202410:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202410:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202409:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202407:58EDGAR2Form 144 - Report of proposed sale of securities
29/02/202407:13EDGAR2Form S-3ASR - Automatic shelf registration statement of..
29/02/202406:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/02/202421:06EDGAR2Form 8-K - Current report
28/02/202421:00GLOBEEditas Medicine Announces Fourth Quarter and Full Year 2023..
21/02/202421:00GLOBEEditas Medicine Announces Fourth Quarter and Full Year 2023..
14/02/202422:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/01/202423:00GLOBEEditas Medicine to Participate in Upcoming Investor..
08/01/202422:15GLOBEEditas Medicine Highlights 2024 Anticipated Milestones and..
03/01/202421:00GLOBEEditas Medicine to Present at the 42nd Annual J.P. Morgan..
14/12/202302:48DJNEditas Medicine Strikes License Deal With Vertex..
13/12/202323:49DJNEditas Medicine Strikes License Deal With Vertex..
13/12/202323:02EDGAR2Form 8-K - Current report
13/12/202323:00GLOBEEditas Medicine and Vertex Pharmaceuticals Enter into..
12/12/202306:23EDGAR2Form 8-K - Current report
12/12/202302:00GLOBEEditas Medicine Announces New EDIT-301 Safety and Efficacy..
08/12/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202306:10EDGAR2Form 8-K - Current report
17/11/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202306:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202305:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202320:06EDGAR2Form 8-K - Current report
03/11/202320:00GLOBEEditas Medicine Announces Third Quarter 2023 Results and..
02/11/202322:12GLOBEEditas Medicine to Present Clinical Data from the RUBY and..
27/10/202320:00GLOBEEditas Medicine Announces Third Quarter 2023 Results..
16/10/202321:00GLOBEEditas Medicine Granted FDA Regenerative Medicine Advanced..
11/10/202305:05EDGAR2Form 8-K - Current report
26/09/202305:30GLOBEEditas Medicine Reports Inducement Grants to New Chief..
25/09/202322:00GLOBEEditas Medicine Strengthens Executive Leadership Team with..
08/09/202305:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/08/202322:00GLOBEEditas Medicine Announces Upcoming Investor Events
28/08/202320:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
16/08/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/08/202305:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/08/202320:16EDGAR2Form 8-K - Current report
02/08/202320:00GLOBEEditas Medicine Announces Second Quarter 2023 Results and..
27/07/202322:00GLOBEEditas Medicine and Azzur Group Expand Partnership to..
26/07/202320:00GLOBEEditas Medicine Announces Second Quarter 2023 Results..
26/07/202305:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/07/202305:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/07/202321:00GLOBEEditas Medicine Reports Inducement Grant to New Chief..
24/07/202320:00GLOBEEditas Medicine Strengthens Executive Leadership Team with..
22/07/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

Delayed Upgrade Clock